CMTM6-沉默微生物免疫疗法重编程PDAC瘤并恢复T细胞功能
bioRxiv : the preprint server for biology
|February 9, 2026
概括
这项研究介绍了iSTORM,一种新的微生物免疫疗法,通过殖民瘤和增强抗瘤免疫反应来向胰腺癌 (PDAC). iSTORM证明了T细胞激活和瘤控制的改善,为PDAC提供了一个有前途的新治疗策略.
科学领域:
- 微生物免疫疗法是一种微生物免疫疗法.
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 胰腺管腺癌 (PDAC) 在很大程度上对当前的免疫疗法具有抗性.
- 密度纤维化和免疫抑制限制了T细胞在PDAC中的透.
- 以前的减弱型沙门氏菌株显示出有限的疗效和安全问题.
研究的目的:
- 评估CRC2631及其衍生品iSTORM用于PDAC治疗的瘤向,免疫重塑和安全概况.
- 设计下一代微生物疗法,以增强PDAC中的抗瘤免疫力.
主要方法:
- 使用了减弱的Salmonella enterica血清 Typhimurium菌株CRC2631及其衍生物iSTORM.
- 在PDAC模型中评估了瘤殖民,免疫细胞透和转录变化.
- 研究了CMTM6沉默及其对PD-L1表达和T细胞激活的影响.
- 进行了毒性研究,以评估iSTORM的安全性.
主要成果:
- CRC2631和iSTORM首选殖民了PDAC瘤. 这两种瘤是最常见的.
- iSTORM增强了内CD8+T细胞,并促进了T细胞的激活.
- 与CRC2631.1.相比,iSTORM显示出更深层次的瘤控制.
- 溶解型iSTORM配方保留了免疫重塑和提高了部署能力.
- 在毒性研究中,iSTORM表现出良好的安全性.
结论:
- iSTORM是一种安全有效的微生物免疫疗法平台,用于PDAC.
- iSTORM选择性地准PDAC瘤,重塑瘤微环境,并释放抗瘤免疫活性.
- 这种以甘氨酸为导向,针对CMTM6的细菌平台具有可扩展的PDAC治疗和其他免疫冷瘤的潜力.
相关概念视频
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Restorative Care
2.4K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
2.4K
Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
Loss of Tumor Suppressor Gene Functions
6.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Introduction to Nuclear Reprogramming
2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K


